Published in J Control Release on November 29, 2007
Arginine-grafted bioreducible poly(disulfide amine) for gene delivery systems. Biomaterials (2008) 1.55
A family of bioreducible poly(disulfide amine)s for gene delivery. Biomaterials (2009) 1.10
Acetylation of PAMAM dendrimers for cellular delivery of siRNA. BMC Biotechnol (2009) 1.08
Mannosylated bioreducible nanoparticle-mediated macrophage-specific TNF-α RNA interference for IBD therapy. Biomaterials (2013) 0.97
Enhanced gene delivery using disulfide-crosslinked low molecular weight polyethylenimine with listeriolysin o-polyethylenimine disulfide conjugate. J Control Release (2008) 0.97
Nanotoxicity: a key obstacle to clinical translation of siRNA-based nanomedicine. Nanomedicine (Lond) (2014) 0.94
Bioreducible polycations in nucleic acid delivery: past, present, and future trends. Macromol Biosci (2014) 0.93
Influence of the molecular weight of bioreducible oligoethylenimine conjugates on the polyplex transfection properties. AAPS J (2009) 0.89
Degradable polymer-coated gold nanoparticles for co-delivery of DNA and siRNA. Acta Biomater (2014) 0.88
Theranostic nanoparticles based on bioreducible polyethylenimine-coated iron oxide for reduction-responsive gene delivery and magnetic resonance imaging. Int J Nanomedicine (2014) 0.86
Safety profiles and antitumor efficacy of oncolytic adenovirus coated with bioreducible polymer in the treatment of a CAR negative tumor model. Biomacromolecules (2014) 0.85
Degradable polyethylenimine derivate coupled to a bifunctional peptide R13 as a new gene-delivery vector. Int J Nanomedicine (2012) 0.83
Incorporation of 2,3-diaminopropionic acid into linear cationic amphipathic peptides produces pH-sensitive vectors. Chembiochem (2010) 0.83
A pH and redox dual responsive 4-arm poly(ethylene glycol)-block-poly(disulfide histamine) copolymer for non-viral gene transfection in vitro and in vivo. Int J Mol Sci (2014) 0.82
A comparative study of three ternary complexes prepared in different mixing orders of siRNA/redox-responsive hyperbranched poly (amido amine)/hyaluronic acid. Int J Nanomedicine (2012) 0.82
Development of protein mimics for intracellular delivery. Biopolymers (2015) 0.81
Coupling of a bifunctional peptide R13 to OTMCS-PEI copolymer as a gene vector increases transfection efficiency and tumor targeting. Int J Nanomedicine (2014) 0.79
Degradable polymers for gene delivery. Conf Proc IEEE Eng Med Biol Soc (2009) 0.78
Bioreducible polycations as shuttles for therapeutic nucleic acid and protein transfection. Antioxid Redox Signal (2014) 0.76
Biocleavable Polycationic Micelles as Highly Efficient Gene Delivery Vectors. Nanoscale Res Lett (2010) 0.75
Novel guanidinylated bioresponsive poly(amidoamine)s designed for short hairpin RNA delivery. Int J Nanomedicine (2016) 0.75
Guanidinylated bioresponsive poly(amido amine)s designed for intranuclear gene delivery. Int J Nanomedicine (2016) 0.75
Oligonucleotide-based theranostic nanoparticles in cancer therapy. Nanomedicine (Lond) (2016) 0.75
Identification of formaldehyde-induced modifications in proteins: reactions with model peptides. J Biol Chem (2003) 2.60
Drug targeting to tumors: principles, pitfalls and (pre-) clinical progress. J Control Release (2011) 2.37
Sheddable coatings for long-circulating nanoparticles. Pharm Res (2007) 2.15
Protein immobilization strategies for protein biochips. Biomacromolecules (2007) 2.10
Theranostic nanomedicine. Acc Chem Res (2011) 1.84
Polymeric micelles in anticancer therapy: targeting, imaging and triggered release. Pharm Res (2010) 1.83
Stimuli-responsive polymersomes for programmed drug delivery. Biomacromolecules (2009) 1.80
Reducible poly(amido ethylenimine)s designed for triggered intracellular gene delivery. Bioconjug Chem (2006) 1.77
Micromechanical testing of individual collagen fibrils. Macromol Biosci (2006) 1.75
A review on stereolithography and its applications in biomedical engineering. Biomaterials (2010) 1.71
Reduction-sensitive polymers and bioconjugates for biomedical applications. Biomaterials (2009) 1.70
Biodegradable polymers as non-viral carriers for plasmid DNA delivery. J Control Release (2007) 1.64
Nanotheranostics and image-guided drug delivery: current concepts and future directions. Mol Pharm (2010) 1.60
Novel bioreducible poly(amido amine)s for highly efficient gene delivery. Bioconjug Chem (2007) 1.56
25th anniversary article: Engineering hydrogels for biofabrication. Adv Mater (2013) 1.54
Artificial viruses: a nanotechnological approach to gene delivery. Nat Rev Drug Discov (2006) 1.52
Glutathione-responsive nano-vehicles as a promising platform for targeted intracellular drug and gene delivery. J Control Release (2011) 1.52
Hydrogels for protein delivery. Chem Rev (2012) 1.44
Intratumoral administration of holmium-166 acetylacetonate microspheres: antitumor efficacy and feasibility of multimodality imaging in renal cancer. PLoS One (2013) 1.42
Hydrogels as extracellular matrices for skeletal tissue engineering: state-of-the-art and novel application in organ printing. Tissue Eng (2007) 1.42
In situ gelling hydrogels for pharmaceutical and biomedical applications. Int J Pharm (2008) 1.41
The effect of photopolymerization on stem cells embedded in hydrogels. Biomaterials (2008) 1.39
Micromechanical bending of single collagen fibrils using atomic force microscopy. J Biomed Mater Res A (2007) 1.38
Passive versus active tumor targeting using RGD- and NGR-modified polymeric nanomedicines. Nano Lett (2014) 1.37
Identification of formaldehyde-induced modifications in proteins: reactions with insulin. Bioconjug Chem (2006) 1.37
Mechanical properties of native and cross-linked type I collagen fibrils. Biophys J (2007) 1.36
Reducible poly(amido ethylenimine) directed to enhance RNA interference. Biomaterials (2007) 1.35
Co-delivery of siRNA and paclitaxel into cancer cells by biodegradable cationic micelles based on PDMAEMA-PCL-PDMAEMA triblock copolymers. Biomaterials (2009) 1.34
Dual and multi-stimuli responsive polymeric nanoparticles for programmed site-specific drug delivery. Biomaterials (2013) 1.34
Cyclodextrin-based polymeric materials: synthesis, properties, and pharmaceutical/biomedical applications. Biomacromolecules (2009) 1.33
Hydrolysable core-crosslinked thermosensitive polymeric micelles: synthesis, characterisation and in vivo studies. Biomaterials (2007) 1.30
Reversibly stabilized multifunctional dextran nanoparticles efficiently deliver doxorubicin into the nuclei of cancer cells. Angew Chem Int Ed Engl (2009) 1.30
Porous polymeric structures for tissue engineering prepared by a coagulation, compression moulding and salt leaching technique. Biomaterials (2003) 1.29
Linear poly(amido amine)s with secondary and tertiary amino groups and variable amounts of disulfide linkages: synthesis and in vitro gene transfer properties. J Control Release (2006) 1.26
Chitosan-based delivery systems for protein therapeutics and antigens. Adv Drug Deliv Rev (2009) 1.26
Organ printing: the future of bone regeneration? Trends Biotechnol (2011) 1.26
Polymersomes for drug delivery: design, formation and characterization. J Control Release (2011) 1.25
Effect of cationic carriers on the pharmacokinetics and tumor localization of nucleic acids after intravenous administration. Int J Pharm (2006) 1.25
Synthesis and characterization of hyperbranched polyglycerol hydrogels. Biomaterials (2006) 1.24
Simultaneous delivery of doxorubicin and gemcitabine to tumors in vivo using prototypic polymeric drug carriers. Biomaterials (2009) 1.24
The immunogenicity of polyethylene glycol: facts and fiction. Pharm Res (2013) 1.24
Regionalized GC content of template DNA as a predictor of PCR success. Nucleic Acids Res (2003) 1.24
Mechanical properties of single electrospun collagen type I fibers. Biomaterials (2008) 1.23
Nonnatural amino acids for site-specific protein conjugation. Bioconjug Chem (2009) 1.18
Biodegradable polymersomes as a basis for artificial cells: encapsulation, release and targeting. J Control Release (2005) 1.17
Core-crosslinked polymeric micelles with controlled release of covalently entrapped doxorubicin. Biomaterials (2010) 1.17
How to screen non-viral gene delivery systems in vitro? J Control Release (2011) 1.17
A versatile family of degradable non-viral gene carriers based on hyperbranched poly(ester amine)s. J Control Release (2005) 1.16
Pulsed in vitro release and in vivo behavior of exploding microcapsules. J Control Release (2009) 1.15
Ligand-directed active tumor-targeting polymeric nanoparticles for cancer chemotherapy. Biomacromolecules (2014) 1.14
Preparation and characterization of protein-loaded N-trimethyl chitosan nanoparticles as nasal delivery system. J Control Release (2005) 1.13
Validation of human periodontal ligament-derived cells as a reliable source for cytotherapeutic use. J Clin Periodontol (2010) 1.12
pH-Sensitive degradable polymersomes for triggered release of anticancer drugs: a comparative study with micelles. J Control Release (2009) 1.11
A microfluidic wound-healing assay for quantifying endothelial cell migration. Am J Physiol Heart Circ Physiol (2009) 1.10
Endosomal escape of polymeric gene delivery complexes is not always enhanced by polymers buffering at low pH. Biomacromolecules (2004) 1.09
The nuclear pore complex: the gateway to successful nonviral gene delivery. Pharm Res (2006) 1.07
Degradable-brushed pHEMA-pDMAEMA synthesized via ATRP and click chemistry for gene delivery. Bioconjug Chem (2007) 1.06
Reducible poly(amido ethylenediamine) for hypoxia-inducible VEGF delivery. J Control Release (2006) 1.06
The in vivo and in vitro degradation behavior of poly(trimethylene carbonate). Biomaterials (2005) 1.05
Polyethylene glycol-grafted polystyrene particles. J Biomed Mater Res A (2004) 1.05
A poly(D,L-lactide) resin for the preparation of tissue engineering scaffolds by stereolithography. Biomaterials (2009) 1.04
Hydrogels for protein delivery in tissue engineering. J Control Release (2012) 1.04
Self-assembly of recombinant amphiphilic oligopeptides into vesicles. Biomacromolecules (2007) 1.02
Challenges for the effective molecular imprinting of proteins. Biomaterials (2011) 1.02
Sensitive spectroscopic detection of large and denatured protein aggregates in solution by use of the fluorescent dye Nile red. J Fluoresc (2007) 1.02
Shifting paradigms: biopharmaceuticals versus low molecular weight drugs. Int J Pharm (2003) 1.02
Rapidly in situ-forming degradable hydrogels from dextran thiols through Michael addition. Biomacromolecules (2007) 1.02
Superparamagnetic iron oxide nanoparticles encapsulated in biodegradable thermosensitive polymeric micelles: toward a targeted nanomedicine suitable for image-guided drug delivery. Langmuir (2009) 1.02
Designed biodegradable hydrogel structures prepared by stereolithography using poly(ethylene glycol)/poly(D,L-lactide)-based resins. J Control Release (2010) 1.01
Local perivascular delivery of anti-restenotic agents from a drug-eluting poly(epsilon-caprolactone) stent cuff. Biomaterials (2005) 1.01
Functional aliphatic polyesters for biomedical and pharmaceutical applications. J Control Release (2011) 1.01
Synthesis and applications of biomedical and pharmaceutical polymers via click chemistry methodologies. Bioconjug Chem (2009) 1.01
Enzyme-catalyzed crosslinkable hydrogels: emerging strategies for tissue engineering. Biomaterials (2011) 1.01
Release of anti-restenosis drugs from poly(ethylene oxide)-poly(DL-lactic-co-glycolic acid) nanoparticles. J Control Release (2006) 1.00
Biodegradable elastomeric scaffolds for soft tissue engineering. J Control Release (2003) 0.99
Fumaric acid monoethyl ester-functionalized poly(D,L-lactide)/N-vinyl-2-pyrrolidone resins for the preparation of tissue engineering scaffolds by stereolithography. Biomacromolecules (2009) 0.99
Thermosensitive and biodegradable polymeric micelles for paclitaxel delivery. J Control Release (2005) 0.98
Biodegradable micelles with sheddable poly(ethylene glycol) shells for triggered intracellular release of doxorubicin. Biomaterials (2009) 0.98